Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Rubicon Research Limited ( (IN:RUBICON) ) is now available.
Rubicon Research Limited has allotted 341,815 fully paid-up equity shares of INR 1 each following the exercise of employee stock options under its 2022 Employee Stock Option Scheme. This allotment reflects the company’s ongoing use of equity-based incentives to reward and retain staff.
As a result of the ESOP exercise, Rubicon’s issued, subscribed and paid-up equity share capital has increased to INR 16,50,92,124, comprising an equal number of equity shares of face value INR 1 each. The change marginally dilutes existing shareholders but underscores the company’s commitment to aligning employee interests with long-term shareholder value.
More about Rubicon Research Limited
Rubicon Research Limited is an India-based company listed on BSE and NSE, operating in the pharmaceutical and life sciences research sector. The company develops and manufactures specialized drug formulations and related products, serving regulated markets with a focus on innovation-driven research and development.
Average Trading Volume: 19,050
Technical Sentiment Signal: Strong Buy
See more data about RUBICON stock on TipRanks’ Stock Analysis page.